GENERAL MEDICINE: GnRH Antagonist Protects of Ovarian Function During Chemotherapy

Audio Journal of Medicine, August 2nd 2007 Reporting from: 23RD Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France GnRH Antagonist Protects of Ovarian Function During Chemotherapy REFERENCE: O-144 KATE STERN, Royal Women's Hospital, Melbourne A potential new way of preserving ovarian function during chemotherapy for cancer could be treatment with an antagonist of gonadotropin-releasing hormone: GnRH. A pilot study from Melbourne looked at 18 young women with cancer or auto immune disease due to receive cyclophosphamide therapy. Sarah Maxwell spoke with Kate Stern and heard more about the study.